Company intelligence / Profile preview

Hainan Zhonghua United Pharmaceutical Industry

Haikou, Hainan, China

Ownership: Private
Development stage: Other

Overview

Hainan Zhonghua United Pharmaceutical Industry is a Chinese pharmaceutical company based in the Hainan Free Trade Port. The company focuses on the research, development, and large-scale manufacturing of finished dosage forms, including tablets, capsules, and granules. Its product portfolio primarily covers therapeutic areas such as anti-infectives, digestive health, and cardiovascular medicine. The company operates GMP-certified manufacturing facilities and serves both domestic and international markets through its distribution networks.

Therapeutic areas: Infectious DiseasesGastroenterologyCardiovascularPulmonology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Hainan Zhonghua United Pharmaceutical Industry.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hainan Zhonghua United Pharmaceutical Industry.

Explore the full profile